On October 24, Intuitive Surgical rose 3.01% in Regular Trading, trading at $457.01 per share, with turnover of $657 million.
The move followed a price-target increase from Rothschild & Co Redburn, which lifted its target to $560 from $540, supporting sentiment after the company’s recent earnings release.
Background context shows Intuitive Surgical reported third-quarter adjusted EPS of $3.00 and revenue of $3.049 billion, both above market expectations. Even so, management tightened its outlook for da Vinci procedure growth, with procedure momentum facing potential pressure from US pricing actions and reduced China charge codes. The latest target increase suggests some analysts still see durable medium- to long-term competitiveness and resilience in the company’s fundamentals.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments